Zurich, Switzerland

Gerhard Muhrer

This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Novartis Ag. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerhard Muhrer. Retrieved from https://idiyas.com/inventor/gerhard-muhrer-ainua0ow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gerhard Muhrer: Innovator in Pharmaceutical Compositions

Introduction

Gerhard Muhrer is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of micronization of active agents. His work has implications for the effectiveness and delivery of pharmaceutical compositions.

Latest Patents

Gerhard Muhrer holds a patent for a process related to pharmaceutical compositions. This patent focuses on the micronization of pharmaceutically active agents, which is crucial for enhancing the solubility and bioavailability of medications. He has 1 patent to his name.

Career Highlights

Muhrer is associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to engage in cutting-edge research and development in the pharmaceutical sector. His expertise in micronization processes has contributed to advancements in drug formulation.

Collaborations

Some of his notable coworkers include Anton Baumberger and Ricardo Schneeberger. Their collaborative efforts have furthered research initiatives within Novartis, enhancing the company's innovative capabilities.

Conclusion

Gerhard Muhrer exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the micronization of active agents, have the potential to improve drug delivery systems significantly. His work continues to influence the field and drive advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…